The Hepatocyte Growth Factors (HGFs) Market is witnessing significant growth as global healthcare and biotechnology sectors increasingly leverage HGFs for research, therapeutic development, and clinical applications. Valued at US$ 71,786.23 million in 2024, the market is projected to grow at a CAGR of 5.6% from 2025 to 2032. This growth is fueled by rising prevalence of liver disorders,...